Hirashima, Yutaro
Nakano, Toshiaki
Torisu, Kumiko
Aihara, Seishi
Wakisaka, Masanori
Kitazono, Takanari
Funding for this research was provided by:
The research grant by Taisho Pharmaceutical Co.
Article History
Received: 5 June 2024
Accepted: 27 August 2024
First Online: 2 September 2024
Competing interests
: This work received the research grant by Taisho Pharmaceutical Co., the manufacturer of luseogliflozin. The funding entity did not participate in the study's design, data gathering and analysis, decision to publish, or manuscript preparation, with the sole exception of supplying pharmacokinetic data for luseogliflozin. All the authors declare no conflict of interest.